Privia Health price target raised to $29 from $26 at Canaccord
The Fly

Privia Health price target raised to $29 from $26 at Canaccord

Canaccord raised the firm’s price target on Privia Health (PRVA) to $29 from $26 and keeps a Buy rating on the shares. The firm said Privia delivered another quarter of executing its growth strategy that produced predictable results coming in ahead of expectations with implemented providers, practice collections, and revenue beating estimates.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App